Metabolic Disturbance Clinical Trial
Official title:
Early Tracheostomy in COVID-19 Critically Ill Patients: A Retrospective Case Series
Objective of this case series was to evaluate the characteristics of early COVID-19 tracheostomy and its effect on laboratory parameters. A series of 17 patients with COVID-19undergo surgical tracheostomy in our intensive care unit. Demographic parameters, duration indicators, and laboratory parameters before and after tracheostomy were analyzed in patients. Of the 17 patients, 4 were men and 13 women with a mean age of 59 years. The average length of total hospitalization were 12 days, the length of stay in intensive care were 10 days, the length of endotracheal intubation were 9 days, with the seventh day of tracheotomy. Neurological and thyroid diseases and withdrawal had a statistically significant difference (p <0.05), with laboratory parameters without statistically difference. Critically ill COVID-19 patients undergoing early tracheostomy has a lower possibility of weaning from mechanical ventilation, and early tracheostomy itself has no significant effect on renal parameters, lactate and D-Dimer.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04528004 -
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
|
Early Phase 1 | |
Completed |
NCT04597983 -
Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists
|
N/A | |
Completed |
NCT03445234 -
Blueberries, Bananas, Exercise Recovery
|
N/A | |
Recruiting |
NCT04892199 -
Does GLP-1RA Prevent Deterioration of Metabolic State in Prediabetic and Diabetic Patients Treated With Antipsychotic Medication?
|
Phase 4 | |
Active, not recruiting |
NCT05070585 -
Isothiocyanates and Metabolic Health
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05494151 -
Metabolic Substrate of Patients With Myocardial Infarction With and Without Modifiable Cardiovascular Risk Factors
|
||
Completed |
NCT04787952 -
Insight Into New Brown Adipose Tissue Activators.
|
||
Completed |
NCT05758857 -
Multiple Risk Factor Intervention Trial
|
N/A | |
Completed |
NCT02689882 -
"Pharmacokinetic Study of Nicotinamide Riboside"
|
Phase 1 | |
Completed |
NCT01674426 -
Pathogenesis of Functional Hypothalamic Amenorrhea
|
N/A | |
Recruiting |
NCT06252922 -
Diet-Induced Changes in GEnetic Material
|
||
Completed |
NCT06326840 -
Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment
|
N/A | |
Recruiting |
NCT06345937 -
Multiple Risk Factor Intervention Trial (Ms. FIT)
|
N/A | |
Recruiting |
NCT06392360 -
Betaine, Exercise Performance, and Gut Permeability
|
N/A | |
Completed |
NCT04009642 -
Cardiac Rest and Stress Metabolism in Patients With Type 2 Diabetes
|
||
Withdrawn |
NCT03515642 -
Exercise, Gut Microbiota in Sedentary Adults With Overweight
|
N/A | |
Recruiting |
NCT06333184 -
Smoothies and Blood Sugars
|
N/A | |
Not yet recruiting |
NCT05773183 -
Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men
|
||
Completed |
NCT04266665 -
Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome
|
Phase 4 | |
Completed |
NCT03697928 -
Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability
|